AJU IB Investment Co., Ltd. - Q2 2021 holdings

$173 Million is the total value of AJU IB Investment Co., Ltd.'s 11 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .

 Value Shares↓ Weighting
APLS SellAPELLIS PHARMACEUTICALS INC$67,306,000
+40.7%
1,064,962
-4.5%
38.81%
+115.0%
AVIR SellATEA PHARMACEUTICALS INC$37,490,000
-70.4%
1,745,331
-14.8%
21.62%
-54.7%
KYMR  KYMERA THERAPEUTICS INC$30,994,000
+24.8%
639,0590.0%17.87%
+90.8%
SEER SellSEER INC$26,761,000
-49.8%
816,375
-23.4%
15.43%
-23.3%
STRO  SUTRO BIOPHARMA INC$3,253,000
-18.3%
175,0000.0%1.88%
+24.9%
RAPT SellRAPT THERAPEUTICS INC$3,163,000
+31.3%
99,503
-8.3%
1.82%
+100.7%
MTEM  MOLECULAR TEMPLATES INC$1,602,000
-38.0%
204,8090.0%0.92%
-5.2%
CLSD SellCLEARSIDE BIOMEDICAL INC$1,430,000
-27.0%
293,555
-63.0%
0.82%
+11.6%
KZR  KEZAR LIFE SCIENCES INC$700,000
-8.9%
128,9160.0%0.40%
+39.3%
ALRN  AILERON THERAPEUTICS INC$647,000
-12.6%
517,5580.0%0.37%
+33.7%
 BELLICUM PHARMACEUTICALS INC$85,000
-11.5%
25,6510.0%0.05%
+36.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC8Q3 202240.4%
SEER INC8Q3 202225.9%
RAPT THERAPEUTICS INC8Q3 20225.1%
SUTRO BIOPHARMA INC8Q3 20223.6%
ATEA PHARMACEUTICALS INC4Q3 202147.7%
APELLIS PHARMACEUTICALS INC4Q3 202138.8%
RALLYBIO CORP4Q3 202218.7%
XILIO THERAPEUTICS INC4Q3 202214.9%
CLEARSIDE BIOMEDICAL INC4Q3 20211.1%
MOLECULAR TEMPLATES INC4Q3 20211.0%

View AJU IB Investment Co., Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR/A2022-11-14
13F-HR2022-11-07
13F-HR2022-08-09
13F-HR2022-05-12
13F-HR2022-02-09
13F-HR2021-11-10
13F-HR2021-08-10
13F-HR2021-05-12
13F-HR2021-05-12
42017-11-13

View AJU IB Investment Co., Ltd.'s complete filings history.

Compare quarters

Export AJU IB Investment Co., Ltd.'s holdings